Enhancing the Analytical toolbox to analyze co-purifying Host Cell Proteins presence: N-(4)-(β-acetylglucosaminyl)-L-asparaginase case research
Ranges of host cell proteins (HCP) in purification intermediates and drug substances (DS) of monoclonal antibodies (mAb) should be rigorously monitored for the manufacturing of secure and efficacious biotherapeutics. In the course of the improvement of mAb1, an IgG1 product, sudden outcomes generated with HCP ELISA equipment triggered an investigation which led to the identification of a co-purifying HCP known as N-(4)-(β-acetylglucosaminyl)-L-asparaginase (AGA, EC3.5.1.26) by LC-MS/MS.
The danger evaluation carried out indicated a low immunogenicity danger for the co-purifying HCP and an ad-hoc stability research demonstrated no mAb glycan cleavage and thus no influence on product high quality.
DOCK2 {couples} with LEF-1 to control B cell metabolism and reminiscence
Dedicator of cytokinesis 2 (DOCK2) is important for the B cell differentiation, BCR signaling and humoral immune response.
Fractionation research carried out on sharpening steps revealed that AGA was co-eluted with the mAb. Very apparently, the native digestion protocol carried out to go deeper within the MS HCP profiling was discovered to be incompatible with correct AGA detection in final purification intermediate and DS, additional suggesting a hitchhiking conduct of AGA. In silico floor characterization of AGA additionally helps this speculation. Lastly, the mixed assist of HCP ELISA outcomes and mass spectrometry allowed course of optimization and removing of this co-purifying HCP. This text is protected by copyright. All rights reserved.
Key phrases: AGA N-(4)-(β-acetylglucosaminyl)-L-asparaginase; HCP ELISA assay; HCP identification and quantitation by LC-MS/MS; Hitchhiking conduct; Host Cell Proteins; Threat evaluation.
Nevertheless, the function of DOCK2 within the reminiscence response of B cell is unknown.
Through the use of two DOCK2 poor sufferers, we discovered that the reminiscence B cells have been decreased and the early activation of DOCK2 poor reminiscence B cells was abolished to the diploma of naïve B cells as a result of decreased expression of CD19 and CD21 mechanistically.
Apparently the expression of LEF-1, a adverse regulator of CD21, was elevated in DOCK2 poor B cells.
This was linked to the elevated expression of HIF-1α and cell metabolism, which in flip affected the ER construction.
nfkb-p65
Lastly, the discount of reminiscence B cells in DOCK2 sufferers was as a result of elevated apoptosis, which may be associated with the elevated metabolism.
Identification of Retinal Ganglion Cells from β-III Stained Fluorescent Microscopic Photos
Optic nerve crush in mouse mannequin is broadly used for investigating the course following retinal ganglion cell (RGCs) damage.
Handbook cell counting from β-III tubulin stained microscopic photographs has been routinely carried out to watch RGCs after an optic nerve crush damage, however is time-consuming and susceptible to observer variability.
Anti-Dog RBC, IgM Fraction, (Polyclonal) (rabbit IgM) |
MBS524329-5mg |
MyBiosource |
5mg |
EUR 620 |
Anti-Dog RBC, IgM Fraction, (Polyclonal) (rabbit IgM) |
MBS524329-5x5mg |
MyBiosource |
5x5mg |
EUR 2550 |
Anti-Cat RBC, IgM Fraction, (Polyclonal) (rabbit IgM) |
MBS524396-5mg |
MyBiosource |
5mg |
EUR 620 |
Anti-Cat RBC, IgM Fraction, (Polyclonal) (rabbit IgM) |
MBS524396-5x5mg |
MyBiosource |
5x5mg |
EUR 2550 |
Red Blood Cells, Chicken IgM Fraction |
GWB-94168D |
GenWay Biotech |
5 mg |
Ask for price |
Anti-Swine RBC, IgM Fraction, (Polyclonal) (rabbit IgM) |
MBS524203-5mg |
MyBiosource |
5mg |
EUR 620 |
Anti-Swine RBC, IgM Fraction, (Polyclonal) (rabbit IgM) |
MBS524203-5x5mg |
MyBiosource |
5x5mg |
EUR 2550 |
Anti-Human RBC, IgM Fraction, (Polyclonal) (rabbit IgM) |
MBS524352-5mg |
MyBiosource |
5mg |
EUR 620 |
Anti-Human RBC, IgM Fraction, (Polyclonal) (rabbit IgM) |
MBS524352-5x5mg |
MyBiosource |
5x5mg |
EUR 2550 |
Anti-Mouse RBC, IgM Fraction, (Polyclonal) (rabbit IgM) |
MBS524365-5mg |
MyBiosource |
5mg |
EUR 620 |
Anti-Mouse RBC, IgM Fraction, (Polyclonal) (rabbit IgM) |
MBS524365-5x5mg |
MyBiosource |
5x5mg |
EUR 2550 |
Anti-Bovine RBC, IgM Fraction, (Polyclonal) (rabbit IgM) |
MBS524315-5mg |
MyBiosource |
5mg |
EUR 620 |
Anti-Bovine RBC, IgM Fraction, (Polyclonal) (rabbit IgM) |
MBS524315-5x5mg |
MyBiosource |
5x5mg |
EUR 2550 |
Anti-Turkey RBC, IgM Fraction, (Polyclonal) (rabbit IgM) |
MBS524333-5mg |
MyBiosource |
5mg |
EUR 620 |
Anti-Turkey RBC, IgM Fraction, (Polyclonal) (rabbit IgM) |
MBS524333-5x5mg |
MyBiosource |
5x5mg |
EUR 2550 |
Anti-Chicken RBC, IgM Fraction, (Polyclonal) (rabbit IgM) |
MBS524198-5mg |
MyBiosource |
5mg |
EUR 620 |
Anti-Chicken RBC, IgM Fraction, (Polyclonal) (rabbit IgM) |
MBS524198-5x5mg |
MyBiosource |
5x5mg |
EUR 2550 |
Anti-Hamster RBC, IgM Fraction, (Polyclonal) (rabbit IgM) |
MBS524271-5mg |
MyBiosource |
5mg |
EUR 620 |
Anti-Hamster RBC, IgM Fraction, (Polyclonal) (rabbit IgM) |
MBS524271-5x5mg |
MyBiosource |
5x5mg |
EUR 2550 |
Anti-Guinea Pig RBC, IgM Fraction, (Polyclonal) (rabbit IgM) |
MBS524301-5mg |
MyBiosource |
5mg |
EUR 620 |
Anti-Guinea Pig RBC, IgM Fraction, (Polyclonal) (rabbit IgM) |
MBS524301-5x5mg |
MyBiosource |
5x5mg |
EUR 2550 |
Anti-Horse RBC, IgM Fraction, (Polyclonal) (rabbit IgG) |
MBS524261-5mg |
MyBiosource |
5mg |
EUR 620 |
Anti-Horse RBC, IgM Fraction, (Polyclonal) (rabbit IgG) |
MBS524261-5x5mg |
MyBiosource |
5x5mg |
EUR 2550 |
IgG Fraction of anti-Mouse IgM [H&L] [Rabbit] |
SG006 |
ABM |
5.0 mg |
EUR 125 |
IgG Fraction of anti-Mouse IgM [H&L] [Rabbit] |
MBS417924-5mg |
MyBiosource |
5mg |
EUR 275 |
IgG Fraction of anti-Mouse IgM u (mu chain specific) [Goat] |
MBS417923-5mg |
MyBiosource |
5mg |
EUR 275 |
Peroxidase Conjugated IgG fraction of anti-Mouse IgM [H&L] [Goat] |
MBS417936-5mg |
MyBiosource |
5mg |
EUR 300 |
Fluorescein Conjugated IgG fraction of anti-Mouse IgM [H&L] [Rabbit] |
SG013 |
ABM |
5.0 mg |
EUR 200 |
Fluorescein Conjugated IgG fraction of anti-Mouse IgM [H&L] [Rabbit] |
MBS417931-5mg |
MyBiosource |
5mg |
EUR 300 |
BSA Fraction V |
30-AB75 |
Fitzgerald |
1 kg |
Ask for price |
|
Description: Standard Grade Bovine Serum Albumin, Cohn Fraction V, (99% pure) |
Rat Ig fraction |
31R-1021 |
Fitzgerald |
10 mg |
EUR 138 |
Description: Rat Ig fraction control or blocking reagent |
Rat Ig fraction |
31R-1045 |
Fitzgerald |
10 mg |
EUR 91 |
|
Description: Purified Rat Ig fraction for use as a control or blocking reagent |
Rat Ig Fraction |
MBS687022-10mg |
MyBiosource |
10mg |
EUR 155 |
Rat Ig Fraction |
MBS687022-5x10mg |
MyBiosource |
5x10mg |
EUR 545 |
Rat Ig fraction |
MBS5308176-10mg |
MyBiosource |
10mg |
EUR 235 |
Rat Ig fraction |
MBS5308176-5x10mg |
MyBiosource |
5x10mg |
EUR 905 |
BSA Fraction V |
MBS537210-5x1kg |
MyBiosource |
5x1kg |
EUR 16065 |
Goat Ig fraction |
31R-1008 |
Fitzgerald |
10 mg |
EUR 136.8 |
Description: Goat Ig fraction control or blocking reagent |
Goat Ig fraction |
31R-1032 |
Fitzgerald |
10 mg |
EUR 115 |
|
Description: Purified Goat Ig fraction for use as a control or blocking reagent |
Goat Ig Fraction |
MBS687008-10mg |
MyBiosource |
10mg |
EUR 135 |
Goat Ig Fraction |
MBS687008-5x10mg |
MyBiosource |
5x10mg |
EUR 455 |
EGF IgG fraction |
MBS352089-01mL |
MyBiosource |
0.1mL |
EUR 725 |
EGF IgG fraction |
MBS352089-5x01mL |
MyBiosource |
5x0.1mL |
EUR 3190 |
Goat Ig fraction |
MBS5308117-10mg |
MyBiosource |
10mg |
EUR 225 |
Goat Ig fraction |
MBS5308117-5x10mg |
MyBiosource |
5x10mg |
EUR 865 |
Horse Ig fraction |
31R-1005 |
Fitzgerald |
10 mg |
EUR 136.8 |
Description: Horse Ig fraction control or blocking reagent |
Sheep Ig fraction |
31R-1023 |
Fitzgerald |
10 mg |
EUR 136.8 |
Description: Sheep Ig fraction control or blocking reagent |
Horse Ig fraction |
31R-1029 |
Fitzgerald |
10 mg |
EUR 92 |
|
Description: Purified Horse Ig fraction for use as a control or blocking reagent |
Mouse Ig fraction |
31R-1040 |
Fitzgerald |
10 mg |
EUR 128 |
|
Description: Purified Mouse Ig fraction for use as a control or blocking reagent |
Sheep Ig fraction |
31R-1047 |
Fitzgerald |
10 mg |
EUR 92 |
|
Description: Purified Sheep Ig fraction for use as a control or blocking reagent |
Llama Ig Fraction |
MBS689513-10mg |
MyBiosource |
10mg |
EUR 130 |
Llama Ig Fraction |
MBS689513-5x10mg |
MyBiosource |
5x10mg |
EUR 445 |
Horse Ig Fraction |
MBS687004-10mg |
MyBiosource |
10mg |
EUR 135 |
Horse Ig Fraction |
MBS687004-5x10mg |
MyBiosource |
5x10mg |
EUR 455 |
Mouse Ig Fraction |
MBS687017-10mg |
MyBiosource |
10mg |
EUR 170 |
Mouse Ig Fraction |
MBS687017-5x10mg |
MyBiosource |
5x10mg |
EUR 625 |
Sheep Ig Fraction |
MBS687024-10mg |
MyBiosource |
10mg |
EUR 135 |
Sheep Ig Fraction |
MBS687024-5x10mg |
MyBiosource |
5x10mg |
EUR 455 |
LHRH IgG fraction |
MBS352152-01mL |
MyBiosource |
0.1mL |
EUR 680 |
LHRH IgG fraction |
MBS352152-5x01mL |
MyBiosource |
5x0.1mL |
EUR 2985 |
Horse Ig fraction |
MBS5308129-10mg |
MyBiosource |
10mg |
EUR 200 |
Horse Ig fraction |
MBS5308129-5x10mg |
MyBiosource |
5x10mg |
EUR 750 |
This paper describes an automated approach for RGC identification. We developed and validated (i) a delicate cell candidate segmentation scheme and (ii) a classifier that eliminated false positives whereas retaining true positives.
Two main contributions have been made in cell candidate segmentation. First, a homomorphic filter was designed to regulate for the inhomogeneous illumination attributable to uneven penetration of β-III tubulin antibody.
Second, the optimum segmentation parameters for cell detection are extremely image-specific.
To handle this problem, we launched an offline-online parameter tuning strategy.
Offline tuning optimized mannequin parameters primarily based on coaching photographs and on-line tuning additional optimized the parameters on the testing stage without having entry to the bottom fact.
Within the cell identification stage, 31 geometric, statistical and textural options have been extracted from every segmented cell candidate, which was subsequently categorised as true or false positives by assist vector machine.
The homomorphic filter and the web parameter tuning strategy collectively elevated cell recall by 28%.
The complete pipeline attained a recall, precision and coefficient of dedication (r2) of 85.3%, 97.1% and 0.994.
CD48 Antibody (Pan Leukocyte Marker) |
V9323-20UG |
NSJ Bioreagents |
20ug |
EUR 153.3 |
|
Description: Reacts with human CD48, a 45kDa glycosyl phophatidyl-inositol (GPI)-anchored cell surface protein. CD48 is strongly expressed on lymphocytes and monocytes and weakly on granulocytes but is absent on platelets, fibroblasts, epithelium and endothelium. CD48 is one of marker for detecting the defects of GPI anchoring structure on the patients with paroxysmal nocturnal hemoglobulinuria (PNH) and serves as a low affinity ligand for CD2. |
CD48 Antibody (Pan Leukocyte Marker) |
V9323SAF-100UG |
NSJ Bioreagents |
100ug |
EUR 349.3 |
|
Description: Reacts with human CD48, a 45kDa glycosyl phophatidyl-inositol (GPI)-anchored cell surface protein. CD48 is strongly expressed on lymphocytes and monocytes and weakly on granulocytes but is absent on platelets, fibroblasts, epithelium and endothelium. CD48 is one of marker for detecting the defects of GPI anchoring structure on the patients with paroxysmal nocturnal hemoglobulinuria (PNH) and serves as a low affinity ligand for CD2. |
CD48 Antibody (Pan Leukocyte Marker) |
V3016-100UG |
NSJ Bioreagents |
100 ug |
EUR 424.15 |
|
Description: Reacts with human CD48, a 45kDa glycosyl phophatidyl-inositol (GPI)-anchored cell surface protein. CD48 is strongly expressed on lymphocytes and monocytes and weakly on granulocytes but is absent on platelets, fibroblasts, epithelium and endothelium. CD48 is one of marker for detecting the defects of GPI anchoring structure on the patients with paroxysmal nocturnal hemoglobulinuria (PNH) and serves as a low affinity ligand for CD2. |
CD48 Antibody (Pan Leukocyte Marker) |
V3016-20UG |
NSJ Bioreagents |
20 ug |
EUR 186.15 |
|
Description: Reacts with human CD48, a 45kDa glycosyl phophatidyl-inositol (GPI)-anchored cell surface protein. CD48 is strongly expressed on lymphocytes and monocytes and weakly on granulocytes but is absent on platelets, fibroblasts, epithelium and endothelium. CD48 is one of marker for detecting the defects of GPI anchoring structure on the patients with paroxysmal nocturnal hemoglobulinuria (PNH) and serves as a low affinity ligand for CD2. |
CD48 Antibody (Pan Leukocyte Marker) |
V3016SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 424.15 |
|
Description: Reacts with human CD48, a 45kDa glycosyl phophatidyl-inositol (GPI)-anchored cell surface protein. CD48 is strongly expressed on lymphocytes and monocytes and weakly on granulocytes but is absent on platelets, fibroblasts, epithelium and endothelium. CD48 is one of marker for detecting the defects of GPI anchoring structure on the patients with paroxysmal nocturnal hemoglobulinuria (PNH) and serves as a low affinity ligand for CD2. |
CD48 Antibody (Pan Leukocyte Marker) |
V3017-100UG |
NSJ Bioreagents |
100 ug |
EUR 424.15 |
|
Description: Reacts with human CD48, a 45kDa glycosyl phophatidyl-inositol (GPI)-anchored cell surface protein. CD48 is strongly expressed on lymphocytes and monocytes and weakly on granulocytes but is absent on platelets, fibroblasts, epithelium and endothelium. CD48 is one of the markers for detecting the defects of GPI anchoring structure on the patients with paroxysmal nocturnal hemoglobulinuria (PNH) and serves as a low affinity ligand for CD2. |
CD48 Antibody (Pan Leukocyte Marker) |
V3017-20UG |
NSJ Bioreagents |
20 ug |
EUR 186.15 |
|
Description: Reacts with human CD48, a 45kDa glycosyl phophatidyl-inositol (GPI)-anchored cell surface protein. CD48 is strongly expressed on lymphocytes and monocytes and weakly on granulocytes but is absent on platelets, fibroblasts, epithelium and endothelium. CD48 is one of the markers for detecting the defects of GPI anchoring structure on the patients with paroxysmal nocturnal hemoglobulinuria (PNH) and serves as a low affinity ligand for CD2. |
CD48 Antibody (Pan Leukocyte Marker) |
V3017SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 424.15 |
|
Description: Reacts with human CD48, a 45kDa glycosyl phophatidyl-inositol (GPI)-anchored cell surface protein. CD48 is strongly expressed on lymphocytes and monocytes and weakly on granulocytes but is absent on platelets, fibroblasts, epithelium and endothelium. CD48 is one of the markers for detecting the defects of GPI anchoring structure on the patients with paroxysmal nocturnal hemoglobulinuria (PNH) and serves as a low affinity ligand for CD2. |
CD48 Antibody (Pan Leukocyte Marker) |
V4698-100UG |
NSJ Bioreagents |
100ug |
EUR 363.3 |
|
Description: Reacts with human CD48, a 45kDa glycosyl phophatidyl-inositol (GPI)-anchored cell surface protein. CD48 is strongly expressed on lymphocytes and monocytes and weakly on granulocytes but is absent on platelets, fibroblasts, epithelium and endothelium. CD48 is one of marker for detecting the defects of GPI anchoring structure on the patients with paroxysmal nocturnal hemoglobulinuria (PNH) and serves as a low affinity ligand for CD2. |
CD48 Antibody (Pan Leukocyte Marker) |
V4698-20UG |
NSJ Bioreagents |
20ug |
EUR 160.3 |
|
Description: Reacts with human CD48, a 45kDa glycosyl phophatidyl-inositol (GPI)-anchored cell surface protein. CD48 is strongly expressed on lymphocytes and monocytes and weakly on granulocytes but is absent on platelets, fibroblasts, epithelium and endothelium. CD48 is one of marker for detecting the defects of GPI anchoring structure on the patients with paroxysmal nocturnal hemoglobulinuria (PNH) and serves as a low affinity ligand for CD2. |
CD48 Antibody (Pan Leukocyte Marker) |
V4698SAF-100UG |
NSJ Bioreagents |
100ug |
EUR 363.3 |
|
Description: Reacts with human CD48, a 45kDa glycosyl phophatidyl-inositol (GPI)-anchored cell surface protein. CD48 is strongly expressed on lymphocytes and monocytes and weakly on granulocytes but is absent on platelets, fibroblasts, epithelium and endothelium. CD48 is one of marker for detecting the defects of GPI anchoring structure on the patients with paroxysmal nocturnal hemoglobulinuria (PNH) and serves as a low affinity ligand for CD2. |
CD48 Antibody (Pan Leukocyte Marker) |
V4699-100UG |
NSJ Bioreagents |
100ug |
EUR 363.3 |
|
Description: Reacts with human CD48, a 45kDa glycosyl phophatidyl-inositol (GPI)-anchored cell surface protein. CD48 is strongly expressed on lymphocytes and monocytes and weakly on granulocytes but is absent on platelets, fibroblasts, epithelium and endothelium. CD48 is one of marker for detecting the defects of GPI anchoring structure on the patients with paroxysmal nocturnal hemoglobulinuria (PNH) and serves as a low affinity ligand for CD2. |
CD48 Antibody (Pan Leukocyte Marker) |
V4699-20UG |
NSJ Bioreagents |
20ug |
EUR 160.3 |
|
Description: Reacts with human CD48, a 45kDa glycosyl phophatidyl-inositol (GPI)-anchored cell surface protein. CD48 is strongly expressed on lymphocytes and monocytes and weakly on granulocytes but is absent on platelets, fibroblasts, epithelium and endothelium. CD48 is one of marker for detecting the defects of GPI anchoring structure on the patients with paroxysmal nocturnal hemoglobulinuria (PNH) and serves as a low affinity ligand for CD2. |
CD48 Antibody (Pan Leukocyte Marker) |
V4699SAF-100UG |
NSJ Bioreagents |
100ug |
EUR 363.3 |
|
Description: Reacts with human CD48, a 45kDa glycosyl phophatidyl-inositol (GPI)-anchored cell surface protein. CD48 is strongly expressed on lymphocytes and monocytes and weakly on granulocytes but is absent on platelets, fibroblasts, epithelium and endothelium. CD48 is one of marker for detecting the defects of GPI anchoring structure on the patients with paroxysmal nocturnal hemoglobulinuria (PNH) and serves as a low affinity ligand for CD2. |
CD48 Antibody (Pan Leukocyte Marker) |
V4742-100UG |
NSJ Bioreagents |
100ug |
EUR 363.3 |
|
Description: Reacts with human CD48, a 45kDa glycosyl phophatidyl-inositol (GPI)-anchored cell surface protein. CD48 is strongly expressed on lymphocytes and monocytes and weakly on granulocytes but is absent on platelets, fibroblasts, epithelium and endothelium. CD48 is one of marker for detecting the defects of GPI anchoring structure on the patients with paroxysmal nocturnal hemoglobulinuria (PNH) and serves as a low affinity ligand for CD2. |
CD48 Antibody (Pan Leukocyte Marker) |
V4742-20UG |
NSJ Bioreagents |
20ug |
EUR 160.3 |
|
Description: Reacts with human CD48, a 45kDa glycosyl phophatidyl-inositol (GPI)-anchored cell surface protein. CD48 is strongly expressed on lymphocytes and monocytes and weakly on granulocytes but is absent on platelets, fibroblasts, epithelium and endothelium. CD48 is one of marker for detecting the defects of GPI anchoring structure on the patients with paroxysmal nocturnal hemoglobulinuria (PNH) and serves as a low affinity ligand for CD2. |
CD48 Antibody (Pan Leukocyte Marker) |
V4742SAF-100UG |
NSJ Bioreagents |
100ug |
EUR 363.3 |
|
Description: Reacts with human CD48, a 45kDa glycosyl phophatidyl-inositol (GPI)-anchored cell surface protein. CD48 is strongly expressed on lymphocytes and monocytes and weakly on granulocytes but is absent on platelets, fibroblasts, epithelium and endothelium. CD48 is one of marker for detecting the defects of GPI anchoring structure on the patients with paroxysmal nocturnal hemoglobulinuria (PNH) and serves as a low affinity ligand for CD2. |
CD48 Antibody (Pan Leukocyte Marker) |
V4743-100UG |
NSJ Bioreagents |
100ug |
EUR 363.3 |
|
Description: CD48 is strongly expressed on lymphocytes and monocytes and weakly on granulocytes but is absent on platelets, fibroblasts, epithelium and endothelium. |
CD48 Antibody (Pan Leukocyte Marker) |
V4743-20UG |
NSJ Bioreagents |
20ug |
EUR 160.3 |
|
Description: CD48 is strongly expressed on lymphocytes and monocytes and weakly on granulocytes but is absent on platelets, fibroblasts, epithelium and endothelium. |
CD48 Antibody (Pan Leukocyte Marker) |
V4743SAF-100UG |
NSJ Bioreagents |
100ug |
EUR 363.3 |
|
Description: CD48 is strongly expressed on lymphocytes and monocytes and weakly on granulocytes but is absent on platelets, fibroblasts, epithelium and endothelium. |
CD48 Antibody (Pan Leukocyte Marker) |
V4744-100UG |
NSJ Bioreagents |
100ug |
EUR 363.3 |
|
Description: Reacts with human CD48, a 45kDa glycosyl phophatidyl-inositol (GPI)-anchored cell surface protein. CD48 is strongly expressed on lymphocytes and monocytes and weakly on granulocytes but is absent on platelets, fibroblasts, epithelium and endothelium. CD48 is one of marker for detecting the defects of GPI anchoring structure on the patients with paroxysmal nocturnal hemoglobulinuria (PNH) and serves as a low affinity ligand for CD2. |
CD48 Antibody (Pan Leukocyte Marker) |
V4744-20UG |
NSJ Bioreagents |
20ug |
EUR 160.3 |
|
Description: Reacts with human CD48, a 45kDa glycosyl phophatidyl-inositol (GPI)-anchored cell surface protein. CD48 is strongly expressed on lymphocytes and monocytes and weakly on granulocytes but is absent on platelets, fibroblasts, epithelium and endothelium. CD48 is one of marker for detecting the defects of GPI anchoring structure on the patients with paroxysmal nocturnal hemoglobulinuria (PNH) and serves as a low affinity ligand for CD2. |
CD48 Antibody (Pan Leukocyte Marker) |
V4744SAF-100UG |
NSJ Bioreagents |
100ug |
EUR 363.3 |
|
Description: Reacts with human CD48, a 45kDa glycosyl phophatidyl-inositol (GPI)-anchored cell surface protein. CD48 is strongly expressed on lymphocytes and monocytes and weakly on granulocytes but is absent on platelets, fibroblasts, epithelium and endothelium. CD48 is one of marker for detecting the defects of GPI anchoring structure on the patients with paroxysmal nocturnal hemoglobulinuria (PNH) and serves as a low affinity ligand for CD2. |
CD48 (Pan Leukocyte Marker) Mouse Monoclonal Antibody |
MBS439057-002mgWithBSAAzideat02mgmL |
MyBiosource |
0.02mg(WithBSA&Azideat0.2mg/mL) |
EUR 230 |
CD48 (Pan Leukocyte Marker) Mouse Monoclonal Antibody |
MBS439057-01mgWithBSAAzideat02mgmL |
MyBiosource |
0.1mg(WithBSA&Azideat0.2mg/mL) |
EUR 405 |
CD48 (Pan Leukocyte Marker) Mouse Monoclonal Antibody |
MBS439057-01mgWithoutBSAAzideat1mgmL |
MyBiosource |
0.1mg(WithoutBSA&Azideat1mg/mL) |
EUR 405 |
CD48 (Pan Leukocyte Marker) Mouse Monoclonal Antibody |
MBS439057-5x01mgWithBSAAzideat02mgmL |
MyBiosource |
5x0.1mg(WithBSA&Azideat0.2mg/mL) |
EUR 1725 |
CD48 (Pan Leukocyte Marker) Mouse Monoclonal Antibody |
MBS439057-5x01mgWithoutBSAAzideat1mgmL |
MyBiosource |
5x0.1mg(WithoutBSA&Azideat1mg/mL) |
EUR 1725 |
CD48 (Pan Leukocyte Marker) Mouse Monoclonal Antibody |
MBS439328-002mgWithBSAAzideat02mgmL |
MyBiosource |
0.02mg(WithBSA&Azideat0.2mg/mL) |
EUR 230 |
CD48 (Pan Leukocyte Marker) Mouse Monoclonal Antibody |
MBS439328-01mgWithBSAAzideat02mgmL |
MyBiosource |
0.1mg(WithBSA&Azideat0.2mg/mL) |
EUR 405 |
CD48 (Pan Leukocyte Marker) Mouse Monoclonal Antibody |
MBS439328-01mgWithoutBSAAzideat1mgmL |
MyBiosource |
0.1mg(WithoutBSA&Azideat1mg/mL) |
EUR 405 |
CD48 (Pan Leukocyte Marker) Mouse Monoclonal Antibody |
MBS439328-5x01mgWithBSAAzideat02mgmL |
MyBiosource |
5x0.1mg(WithBSA&Azideat0.2mg/mL) |
EUR 1725 |
CD48 (Pan Leukocyte Marker) Mouse Monoclonal Antibody |
MBS439328-5x01mgWithoutBSAAzideat1mgmL |
MyBiosource |
5x0.1mg(WithoutBSA&Azideat1mg/mL) |
EUR 1725 |
CD48 (Pan Leukocyte Marker) Mouse Monoclonal Antibody [Clone CD48/4783] |
MBS4382413-002mgWithBSAAzideat02mgmL |
MyBiosource |
0.02mg(WithBSA&Azideat0.2mg/mL) |
EUR 230 |
CD48 (Pan Leukocyte Marker) Mouse Monoclonal Antibody [Clone CD48/4783] |
MBS4382413-01mgWithBSAAzideat02mgmL |
MyBiosource |
0.1mg(WithBSA&Azideat0.2mg/mL) |
EUR 405 |
CD48 (Pan Leukocyte Marker) Mouse Monoclonal Antibody [Clone CD48/4783] |
MBS4382413-01mgWithoutBSAAzideat1mgmL |
MyBiosource |
0.1mg(WithoutBSA&Azideat1mg/mL) |
EUR 405 |
CD48 (Pan Leukocyte Marker) Mouse Monoclonal Antibody [Clone CD48/4783] |
MBS4382413-5x01mgWithBSAAzideat02mgmL |
MyBiosource |
5x0.1mg(WithBSA&Azideat0.2mg/mL) |
EUR 1725 |
CD48 (Pan Leukocyte Marker) Mouse Monoclonal Antibody [Clone CD48/4783] |
MBS4382413-5x01mgWithoutBSAAzideat1mgmL |
MyBiosource |
5x0.1mg(WithoutBSA&Azideat1mg/mL) |
EUR 1725 |
CD48 (Pan Leukocyte Marker) Mouse Monoclonal Antibody [Clone CD48/4784] |
MBS4382414-002mgWithBSAAzideat02mgmL |
MyBiosource |
0.02mg(WithBSA&Azideat0.2mg/mL) |
EUR 230 |
CD48 (Pan Leukocyte Marker) Mouse Monoclonal Antibody [Clone CD48/4784] |
MBS4382414-01mgWithBSAAzideat02mgmL |
MyBiosource |
0.1mg(WithBSA&Azideat0.2mg/mL) |
EUR 405 |
CD48 (Pan Leukocyte Marker) Mouse Monoclonal Antibody [Clone CD48/4784] |
MBS4382414-01mgWithoutBSAAzideat1mgmL |
MyBiosource |
0.1mg(WithoutBSA&Azideat1mg/mL) |
EUR 405 |
CD48 (Pan Leukocyte Marker) Mouse Monoclonal Antibody [Clone CD48/4784] |
MBS4382414-5x01mgWithBSAAzideat02mgmL |
MyBiosource |
5x0.1mg(WithBSA&Azideat0.2mg/mL) |
EUR 1725 |
CD48 (Pan Leukocyte Marker) Mouse Monoclonal Antibody [Clone CD48/4784] |
MBS4382414-5x01mgWithoutBSAAzideat1mgmL |
MyBiosource |
5x0.1mg(WithoutBSA&Azideat1mg/mL) |
EUR 1725 |
CD48 (Pan Leukocyte Marker) Mouse Monoclonal Antibody [Clone CD48/4785] |
MBS4382415-002mgWithBSAAzideat02mgmL |
MyBiosource |
0.02mg(WithBSA&Azideat0.2mg/mL) |
EUR 230 |
CD48 (Pan Leukocyte Marker) Mouse Monoclonal Antibody [Clone CD48/4785] |
MBS4382415-01mgWithBSAAzideat02mgmL |
MyBiosource |
0.1mg(WithBSA&Azideat0.2mg/mL) |
EUR 405 |
CD48 (Pan Leukocyte Marker) Mouse Monoclonal Antibody [Clone CD48/4785] |
MBS4382415-01mgWithoutBSAAzideat1mgmL |
MyBiosource |
0.1mg(WithoutBSA&Azideat1mg/mL) |
EUR 405 |
CD48 (Pan Leukocyte Marker) Mouse Monoclonal Antibody [Clone CD48/4785] |
MBS4382415-5x01mgWithBSAAzideat02mgmL |
MyBiosource |
5x0.1mg(WithBSA&Azideat0.2mg/mL) |
EUR 1725 |
CD48 (Pan Leukocyte Marker) Mouse Monoclonal Antibody [Clone CD48/4785] |
MBS4382415-5x01mgWithoutBSAAzideat1mgmL |
MyBiosource |
5x0.1mg(WithoutBSA&Azideat1mg/mL) |
EUR 1725 |
CD48 (Pan Leukocyte Marker) Mouse Monoclonal Antibody [Clone CD48/4786] |
MBS4382416-002mgWithBSAAzideat02mgmL |
MyBiosource |
0.02mg(WithBSA&Azideat0.2mg/mL) |
EUR 230 |
CD48 (Pan Leukocyte Marker) Mouse Monoclonal Antibody [Clone CD48/4786] |
MBS4382416-01mgWithBSAAzideat02mgmL |
MyBiosource |
0.1mg(WithBSA&Azideat0.2mg/mL) |
EUR 405 |
CD48 (Pan Leukocyte Marker) Mouse Monoclonal Antibody [Clone CD48/4786] |
MBS4382416-01mgWithoutBSAAzideat1mgmL |
MyBiosource |
0.1mg(WithoutBSA&Azideat1mg/mL) |
EUR 405 |
CD48 (Pan Leukocyte Marker) Mouse Monoclonal Antibody [Clone CD48/4786] |
MBS4382416-5x01mgWithBSAAzideat02mgmL |
MyBiosource |
5x0.1mg(WithBSA&Azideat0.2mg/mL) |
EUR 1725 |
CD48 (Pan Leukocyte Marker) Mouse Monoclonal Antibody [Clone CD48/4786] |
MBS4382416-5x01mgWithoutBSAAzideat1mgmL |
MyBiosource |
5x0.1mg(WithoutBSA&Azideat1mg/mL) |
EUR 1725 |
CD48 (Pan Leukocyte Marker) Mouse Monoclonal Antibody [Clone CD48/4787] |
MBS4382417-002mgWithBSAAzideat02mgmL |
MyBiosource |
0.02mg(WithBSA&Azideat0.2mg/mL) |
EUR 230 |
CD48 (Pan Leukocyte Marker) Mouse Monoclonal Antibody [Clone CD48/4787] |
MBS4382417-01mgWithBSAAzideat02mgmL |
MyBiosource |
0.1mg(WithBSA&Azideat0.2mg/mL) |
EUR 405 |
CD48 (Pan Leukocyte Marker) Mouse Monoclonal Antibody [Clone CD48/4787] |
MBS4382417-01mgWithoutBSAAzideat1mgmL |
MyBiosource |
0.1mg(WithoutBSA&Azideat1mg/mL) |
EUR 405 |
CD48 (Pan Leukocyte Marker) Mouse Monoclonal Antibody [Clone CD48/4787] |
MBS4382417-5x01mgWithBSAAzideat02mgmL |
MyBiosource |
5x0.1mg(WithBSA&Azideat0.2mg/mL) |
EUR 1725 |
CD48 (Pan Leukocyte Marker) Mouse Monoclonal Antibody [Clone CD48/4787] |
MBS4382417-5x01mgWithoutBSAAzideat1mgmL |
MyBiosource |
5x0.1mg(WithoutBSA&Azideat1mg/mL) |
EUR 1725 |
Monoclonal CD48 (Pan Leukocyte Marker) Antibody - With BSA and Azide, Clone: 5-4.8 |
AMM01590G |
Leading Biology |
0.05mg |
EUR 475.2 |
Description: A Monoclonal antibody against Human CD48 (Pan Leukocyte Marker) - With BSA and Azide. The antibodies are raised in Mouse and are from clone 5-4.8. This antibody is applicable in IF, FC |
Monoclonal CD48 (Pan Leukocyte Marker) Antibody - With BSA and Azide, Clone: 156-4H9 |
AMM01588G |
Leading Biology |
0.05mg |
EUR 475.2 |
Description: A Monoclonal antibody against Human CD48 (Pan Leukocyte Marker) - With BSA and Azide. The antibodies are raised in Mouse and are from clone 156-4H9. This antibody is applicable in IF, FC |
Monoclonal CD48 (Pan Leukocyte Marker) Antibody - Without BSA and Azide, Clone: 5-4.8 |
AMM01591G |
Leading Biology |
0.1mg |
EUR 580.8 |
Description: A Monoclonal antibody against Human CD48 (Pan Leukocyte Marker) - Without BSA and Azide. The antibodies are raised in Mouse and are from clone 5-4.8. This antibody is applicable in IF, FC |
Monoclonal CD48 (Pan Leukocyte Marker) Antibody - Without BSA and Azide, Clone: 156-4H9 |
AMM01589G |
Leading Biology |
0.1mg |
EUR 580.8 |
Description: A Monoclonal antibody against Human CD48 (Pan Leukocyte Marker) - Without BSA and Azide. The antibodies are raised in Mouse and are from clone 156-4H9. This antibody is applicable in IF, FC |
Leukocyte Esterase, Human Leukocytes |
MBS173116-1mL |
MyBiosource |
1mL |
EUR 245 |
Leukocyte Esterase, Human Leukocytes |
MBS173116-25mL |
MyBiosource |
25mL |
EUR 1585 |
Leukocyte Esterase, Human Leukocytes |
MBS173116-5mL |
MyBiosource |
5mL |
EUR 530 |
Leukocyte Esterase, Human Leukocytes |
MBS173116-5x25mL |
MyBiosource |
5x25mL |
EUR 6920 |
Leukocyte protein |
30-1168 |
Fitzgerald |
5 ml |
EUR 571 |
|
Description: Purified native Human Leukocyte protein |
Leukocyte protein |
MBS5303636-5mL |
MyBiosource |
5mL |
EUR 1015 |
Leukocyte protein |
MBS5303636-5x5mL |
MyBiosource |
5x5mL |
EUR 4340 |
CD45RA (Leukocyte Marker) |
MBS4381213-002mgWithBSAAzideat02mgmL |
MyBiosource |
0.02mg(WithBSA&Azideat0.2mg/mL) |
EUR 230 |
CD45RA (Leukocyte Marker) |
MBS4381213-01mgWithBSAAzideat02mgmL |
MyBiosource |
0.1mg(WithBSA&Azideat0.2mg/mL) |
EUR 405 |
CD45RA (Leukocyte Marker) |
MBS4381213-01mgWithoutBSAAzideat1mgmL |
MyBiosource |
0.1mg(WithoutBSA&Azideat1mg/mL) |
EUR 405 |
CD45RA (Leukocyte Marker) |
MBS4381213-5x01mgWithBSAAzideat02mgmL |
MyBiosource |
5x0.1mg(WithBSA&Azideat0.2mg/mL) |
EUR 1725 |
CD45RA (Leukocyte Marker) |
MBS4381213-5x01mgWithoutBSAAzideat1mgmL |
MyBiosource |
5x0.1mg(WithoutBSA&Azideat1mg/mL) |
EUR 1725 |
Leukocyte Esterase protein |
30-1167 |
Fitzgerald |
1 mL |
EUR 263 |
|
Description: Purified native Human Leukocyte Esterase protein |
Leukocyte Esterase protein |
MBS5303642-1mL |
MyBiosource |
1mL |
EUR 440 |
Leukocyte Esterase protein |
MBS5303642-5x1mL |
MyBiosource |
5x1mL |
EUR 1755 |
CD100 (Leukocyte Semaphorin) |
MBS601115-01mg |
MyBiosource |
0.1mg |
EUR 625 |
CD100 (Leukocyte Semaphorin) |
MBS601115-5x01mg |
MyBiosource |
5x0.1mg |
EUR 2665 |
LEUKOCYTE ELASTASE, Antibody |
GWB-D078BD |
GenWay Biotech |
0.1 mg |
Ask for price |
Recombinant Pan troglodytes Leukocyte immunoglobulin-like receptor subfamily A member 6 (LILRA6), partial |
MBS1379729-005mgBaculovirus |
MyBiosource |
0.05mg(Baculovirus) |
EUR 1350 |
Recombinant Pan troglodytes Leukocyte immunoglobulin-like receptor subfamily A member 6 (LILRA6), partial |
MBS1379729-005mgMammalianCell |
MyBiosource |
0.05mg(Mammalian-Cell) |
EUR 1605 |
Recombinant Pan troglodytes Leukocyte immunoglobulin-like receptor subfamily A member 6 (LILRA6), partial |
MBS1379729-05mgEColi |
MyBiosource |
0.5mg(E-Coli) |
EUR 1350 |
Recombinant Pan troglodytes Leukocyte immunoglobulin-like receptor subfamily A member 6 (LILRA6), partial |
MBS1379729-05mgYeast |
MyBiosource |
0.5mg(Yeast) |
EUR 1605 |
Recombinant Pan troglodytes Leukocyte immunoglobulin-like receptor subfamily A member 6 (LILRA6), partial |
MBS1379729-1mgEColi |
MyBiosource |
1mg(E-Coli) |
EUR 2180 |
Recombinant Pan troglodytes Leukocyte immunoglobulin-like receptor subfamily B member 5 (LILRB5), partial |
MBS1396753-005mgBaculovirus |
MyBiosource |
0.05mg(Baculovirus) |
EUR 1365 |
Recombinant Pan troglodytes Leukocyte immunoglobulin-like receptor subfamily B member 5 (LILRB5), partial |
MBS1396753-005mgMammalianCell |
MyBiosource |
0.05mg(Mammalian-Cell) |
EUR 1620 |
The availability of the proposed pipeline will enable environment friendly, correct and reproducible RGC quantification required for assessing the loss of life/survival of RGCs in illness fashions.
Key phrases: Cell segmentation; Fluorescent microscopy; Homomorphic filter; On-line parameter tuning; Retinal ganglion cell (RGC)
Liriopesides B induces apoptosis and cell cycle arrest in human non‑small cell lung most cancers cells
Dedicator of cytokinesis 2 (DOCK2) is important for the B cell differentiation, BCR signaling and humoral immune response.
Nevertheless, the function of DOCK2 within the reminiscence response of B cell is unknown.
Through the use of two DOCK2 poor sufferers, we discovered that the reminiscence B cells have been decreased and the early activation of DOCK2 poor reminiscence B cells was abolished to the diploma of naïve B cells as a result of decreased expression of CD19 and CD21 mechanistically.
Apparently the expression of LEF-1, a adverse regulator of CD21, was elevated in DOCK2 poor B cells.
This was linked to the elevated expression of HIF-1α and cell metabolism, which in flip affected the ER construction.
Lastly, the discount of reminiscence B cells in DOCK2 sufferers was as a result of elevated apoptosis, which may be associated with the elevated metabolism.
Key phrases: B cell; DOCK2; LEF-1
B cell zone reticular cell microenvironments form CXCL13 gradient formation
By way of the formation of focus gradients, morphogens drive graded responses to extracellular alerts, thereby fine-tuning cell behaviors in advanced tissues.
Right here we present that the chemokine CXCL13 varieties each soluble and immobilized gradients.
Particularly, CXCL13+follicular reticular cells kind a small-world community of steerage constructions, with pc simulations and optimization evaluation predicting that immobilized gradients created by this community promote B cell trafficking.
In step with this prediction, imaging evaluation present that CXCL13 binds to extracellular matrix parts in situ, constraining its diffusion. CXCL13 solubilization requires the protease cathepsin B that cleaves CXCL13 right into a secure product.
Mice missing cathepsin B show aberrant follicular structure, a phenotype related to efficient B cell homing to however not inside lymph nodes.
Our knowledge thus recommend that reticular cells of the B cell zone generate microenvironments that form each immobilized and soluble CXCL13 gradients
Anti-Dog RBC, IgM Fraction, (Polyclonal) (rabbit IgM) |
MBS524329-5mg |
MyBiosource |
5mg |
EUR 620 |
Anti-Dog RBC, IgM Fraction, (Polyclonal) (rabbit IgM) |
MBS524329-5x5mg |
MyBiosource |
5x5mg |
EUR 2550 |
Anti-Cat RBC, IgM Fraction, (Polyclonal) (rabbit IgM) |
MBS524396-5mg |
MyBiosource |
5mg |
EUR 620 |
Anti-Cat RBC, IgM Fraction, (Polyclonal) (rabbit IgM) |
MBS524396-5x5mg |
MyBiosource |
5x5mg |
EUR 2550 |
Red Blood Cells, Chicken IgM Fraction |
GWB-94168D |
GenWay Biotech |
5 mg |
Ask for price |
Anti-Swine RBC, IgM Fraction, (Polyclonal) (rabbit IgM) |
MBS524203-5mg |
MyBiosource |
5mg |
EUR 620 |
Anti-Swine RBC, IgM Fraction, (Polyclonal) (rabbit IgM) |
MBS524203-5x5mg |
MyBiosource |
5x5mg |
EUR 2550 |
Anti-Human RBC, IgM Fraction, (Polyclonal) (rabbit IgM) |
MBS524352-5mg |
MyBiosource |
5mg |
EUR 620 |
Anti-Human RBC, IgM Fraction, (Polyclonal) (rabbit IgM) |
MBS524352-5x5mg |
MyBiosource |
5x5mg |
EUR 2550 |
Anti-Mouse RBC, IgM Fraction, (Polyclonal) (rabbit IgM) |
MBS524365-5mg |
MyBiosource |
5mg |
EUR 620 |
Anti-Mouse RBC, IgM Fraction, (Polyclonal) (rabbit IgM) |
MBS524365-5x5mg |
MyBiosource |
5x5mg |
EUR 2550 |
Anti-Bovine RBC, IgM Fraction, (Polyclonal) (rabbit IgM) |
MBS524315-5mg |
MyBiosource |
5mg |
EUR 620 |
Anti-Bovine RBC, IgM Fraction, (Polyclonal) (rabbit IgM) |
MBS524315-5x5mg |
MyBiosource |
5x5mg |
EUR 2550 |
Anti-Turkey RBC, IgM Fraction, (Polyclonal) (rabbit IgM) |
MBS524333-5mg |
MyBiosource |
5mg |
EUR 620 |
Anti-Turkey RBC, IgM Fraction, (Polyclonal) (rabbit IgM) |
MBS524333-5x5mg |
MyBiosource |
5x5mg |
EUR 2550 |
Anti-Chicken RBC, IgM Fraction, (Polyclonal) (rabbit IgM) |
MBS524198-5mg |
MyBiosource |
5mg |
EUR 620 |
Anti-Chicken RBC, IgM Fraction, (Polyclonal) (rabbit IgM) |
MBS524198-5x5mg |
MyBiosource |
5x5mg |
EUR 2550 |
Anti-Hamster RBC, IgM Fraction, (Polyclonal) (rabbit IgM) |
MBS524271-5mg |
MyBiosource |
5mg |
EUR 620 |
Anti-Hamster RBC, IgM Fraction, (Polyclonal) (rabbit IgM) |
MBS524271-5x5mg |
MyBiosource |
5x5mg |
EUR 2550 |
Anti-Guinea Pig RBC, IgM Fraction, (Polyclonal) (rabbit IgM) |
MBS524301-5mg |
MyBiosource |
5mg |
EUR 620 |
Anti-Guinea Pig RBC, IgM Fraction, (Polyclonal) (rabbit IgM) |
MBS524301-5x5mg |
MyBiosource |
5x5mg |
EUR 2550 |
Anti-Horse RBC, IgM Fraction, (Polyclonal) (rabbit IgG) |
MBS524261-5mg |
MyBiosource |
5mg |
EUR 620 |
Anti-Horse RBC, IgM Fraction, (Polyclonal) (rabbit IgG) |
MBS524261-5x5mg |
MyBiosource |
5x5mg |
EUR 2550 |
IgG Fraction of anti-Mouse IgM [H&L] [Rabbit] |
SG006 |
ABM |
5.0 mg |
EUR 125 |
IgG Fraction of anti-Mouse IgM [H&L] [Rabbit] |
MBS417924-5mg |
MyBiosource |
5mg |
EUR 275 |
IgG Fraction of anti-Mouse IgM u (mu chain specific) [Goat] |
MBS417923-5mg |
MyBiosource |
5mg |
EUR 275 |
Peroxidase Conjugated IgG fraction of anti-Mouse IgM [H&L] [Goat] |
MBS417936-5mg |
MyBiosource |
5mg |
EUR 300 |
Fluorescein Conjugated IgG fraction of anti-Mouse IgM [H&L] [Rabbit] |
SG013 |
ABM |
5.0 mg |
EUR 200 |
Fluorescein Conjugated IgG fraction of anti-Mouse IgM [H&L] [Rabbit] |
MBS417931-5mg |
MyBiosource |
5mg |
EUR 300 |
BSA Fraction V |
30-AB75 |
Fitzgerald |
1 kg |
Ask for price |
|
Description: Standard Grade Bovine Serum Albumin, Cohn Fraction V, (99% pure) |
Rat Ig fraction |
31R-1021 |
Fitzgerald |
10 mg |
EUR 138 |
Description: Rat Ig fraction control or blocking reagent |
Rat Ig fraction |
31R-1045 |
Fitzgerald |
10 mg |
EUR 91 |
|
Description: Purified Rat Ig fraction for use as a control or blocking reagent |
Rat Ig Fraction |
MBS687022-10mg |
MyBiosource |
10mg |
EUR 155 |
Rat Ig Fraction |
MBS687022-5x10mg |
MyBiosource |
5x10mg |
EUR 545 |
Rat Ig fraction |
MBS5308176-10mg |
MyBiosource |
10mg |
EUR 235 |
Rat Ig fraction |
MBS5308176-5x10mg |
MyBiosource |
5x10mg |
EUR 905 |
BSA Fraction V |
MBS537210-5x1kg |
MyBiosource |
5x1kg |
EUR 16065 |
Goat Ig fraction |
31R-1008 |
Fitzgerald |
10 mg |
EUR 136.8 |
Description: Goat Ig fraction control or blocking reagent |
Goat Ig fraction |
31R-1032 |
Fitzgerald |
10 mg |
EUR 115 |
|
Description: Purified Goat Ig fraction for use as a control or blocking reagent |
Goat Ig Fraction |
MBS687008-10mg |
MyBiosource |
10mg |
EUR 135 |
Goat Ig Fraction |
MBS687008-5x10mg |
MyBiosource |
5x10mg |
EUR 455 |
EGF IgG fraction |
MBS352089-01mL |
MyBiosource |
0.1mL |
EUR 725 |
EGF IgG fraction |
MBS352089-5x01mL |
MyBiosource |
5x0.1mL |
EUR 3190 |
Goat Ig fraction |
MBS5308117-10mg |
MyBiosource |
10mg |
EUR 225 |
Goat Ig fraction |
MBS5308117-5x10mg |
MyBiosource |
5x10mg |
EUR 865 |
Horse Ig fraction |
31R-1005 |
Fitzgerald |
10 mg |
EUR 136.8 |
Description: Horse Ig fraction control or blocking reagent |
Sheep Ig fraction |
31R-1023 |
Fitzgerald |
10 mg |
EUR 136.8 |
Description: Sheep Ig fraction control or blocking reagent |
Horse Ig fraction |
31R-1029 |
Fitzgerald |
10 mg |
EUR 92 |
|
Description: Purified Horse Ig fraction for use as a control or blocking reagent |
Mouse Ig fraction |
31R-1040 |
Fitzgerald |
10 mg |
EUR 128 |
|
Description: Purified Mouse Ig fraction for use as a control or blocking reagent |
Sheep Ig fraction |
31R-1047 |
Fitzgerald |
10 mg |
EUR 92 |
|
Description: Purified Sheep Ig fraction for use as a control or blocking reagent |
Llama Ig Fraction |
MBS689513-10mg |
MyBiosource |
10mg |
EUR 130 |
Llama Ig Fraction |
MBS689513-5x10mg |
MyBiosource |
5x10mg |
EUR 445 |
Horse Ig Fraction |
MBS687004-10mg |
MyBiosource |
10mg |
EUR 135 |
Horse Ig Fraction |
MBS687004-5x10mg |
MyBiosource |
5x10mg |
EUR 455 |
Mouse Ig Fraction |
MBS687017-10mg |
MyBiosource |
10mg |
EUR 170 |
Mouse Ig Fraction |
MBS687017-5x10mg |
MyBiosource |
5x10mg |
EUR 625 |
Sheep Ig Fraction |
MBS687024-10mg |
MyBiosource |
10mg |
EUR 135 |
Sheep Ig Fraction |
MBS687024-5x10mg |
MyBiosource |
5x10mg |
EUR 455 |
LHRH IgG fraction |
MBS352152-01mL |
MyBiosource |
0.1mL |
EUR 680 |
LHRH IgG fraction |
MBS352152-5x01mL |
MyBiosource |
5x0.1mL |
EUR 2985 |
Horse Ig fraction |
MBS5308129-10mg |
MyBiosource |
10mg |
EUR 200 |
Horse Ig fraction |
MBS5308129-5x10mg |
MyBiosource |
5x10mg |
EUR 750 |